Extracellular Matrix Topography Drives Adrenergic to Mesenchymal Transition in Neuroblastoma
Advanced Materials · 2025
DOI: 10.1002/adma.202501526 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Antonios Chronopoulos und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cancer and Blood Disease Institute, Children's Hospital Los Angeles, 4650 Sunset Blvd, Los Angeles, California, 90027, USA. Hauptthemen laut MEDLINE: Extracellular Matrix, Neuroblastoma, Epithelial-Mesenchymal Transition. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Margaret E. Early Medical Research Trust to J.P (PI), CHLA start-up fund, CHLA Core pilot grant.
Abstract (Originalsprache)
Neuroblastoma (NB), the most common extracranial solid tumor in children, exhibits intra‐tumoral heterogeneity with two interconvertible identities: adrenergic (ADRN) and mesenchymal (MES). Compared to ADRN cells, MES cells exhibit phenotypes associated with metastasis and therapy resistance. Thus, the transition from ADRN to MES may contribute to poor clinical outcomes, necessitating further investigation into this ADRN‐to‐MES transition (AMT) to improve clinical responses. The extracellular matrix (ECM), a critical component of the tumor microenvironment (TME), provides structural support and delivers mechanical signals that influence oncogenic processes. This research demonstrates that high‐risk NB tumors contain more topographically aligned ECM fibers than low‐risk NB tumors. Using nano‐fabricated biomaterials designed to mimic the aligned ECM, ECM topography is revealed to drive AMT through transcriptional and epigenetic changes, accompanied by enhanced MES phenotypic features. Furthermore, ECM topography is shown to stimulate Rho‐associated kinase and YAP signaling pathways, which mediate ECM‐driven reprogramming. These findings introduce ECM‐driven AMT as a novel mechanism in NB progression and provide insights into TME‐targeted therapeutic strategies aimed at suppressing MES cells to improve clinical outcomes in NB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer and Blood Disease Institute, Children's Hospital Los Angeles, 4650 Sunset Blvd, Los Angeles, California, 90027, USA.
- Department of Convergence Biosystem Engineering, Chonnam National University, 77 Yongbong-ro, Buk-gu, Gwangju, 61186, South Korea.
- Department of Pediatrics, Keck School of Medicine, University of Southern California, 1975 Zonal Ave, Los Angeles, California, 90033, USA.
ORCID-Profile: JinSeok Park
Förderung
- NCI NIH HHS
- Margaret E. Early Medical Research Trust to J.P (PI)
- CHLA start-up fund, CHLA Core pilot grant
- National Cancer Institute
Zitieren
APA
Chronopoulos, A., Vemula, C. K., Zamloot, V., Chavez, I., Kennedy, R., Kim, W., Bell, D., Pan, Y., Moghimi, B., Kim, J., Asgharzadeh, S., & Park, J. (2025). Extracellular Matrix Topography Drives Adrenergic to Mesenchymal Transition in Neuroblastoma. Advanced Materials. https://doi.org/10.1002/adma.202501526
Vancouver
Chronopoulos A, Vemula CK, Zamloot V, Chavez I, Kennedy R, Kim W, et al. Extracellular Matrix Topography Drives Adrenergic to Mesenchymal Transition in Neuroblastoma. Advanced Materials. 2025. doi:10.1002/adma.202501526
BibTeX
@article{Chronopoulos2025,
author = {Chronopoulos, Antonios and Vemula, Chandra Kaladhar and Zamloot, Vic and Chavez, Ivan and Kennedy, Rebekah and Kim, Woochan and Bell, Devon and Pan, Yuanzhong and Moghimi, Babak and Kim, Jangho and Asgharzadeh, Shahab and Park, JinSeok},
title = {Extracellular Matrix Topography Drives Adrenergic to Mesenchymal Transition in Neuroblastoma},
journal = {Advanced Materials},
year = {2025},
doi = {10.1002/adma.202501526}
}
EUVIMED